Healthy high growth potential

Results

1490

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

1490 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
NYKAA
₹326.751.0%56.5%₹935.5b₹307.92469.048.9%n/aRetail
APOLLO
₹392.950.04%116.6%₹147.8b₹382.50130.841.3%0.06%Capital Goods
MONOLITH
₹820.758.6%101.8%₹17.8b₹960.0077.537.2%n/aMaterials
SAATVIKGL
₹442.95-4.5%n/a₹56.3b₹542.5015.839.6%n/aSemiconductors
543273
₹2,426.00-1.2%187.7%₹59.3b₹2,500.0075.353.9%n/aTransportation
VIKRAMSOLR
₹181.19-5.2%n/a₹65.7b₹246.6014.030.0%n/aSemiconductors
501423
₹3,049.006.7%97.1%₹140.2b₹3,517.6782.533.9%0.1%Capital Goods
EIEL
₹218.76-4.6%-16.1%₹38.4b₹346.0021.037.8%n/aCapital Goods
MIDWESTLTD
₹1,240.10-2.5%n/a₹44.8b₹1,500.0042.859.3%n/aMaterials
SCHNEIDER
₹1,352.000.8%51.6%₹323.3b₹1,398.33152.134.0%n/aCapital Goods
FWRY
ج.م19.06-0.7%46.1%ج.م64.9bج.م22.4524.427.3%n/aDiversified Financials
MDGL
US$551.252.9%87.4%US$12.6bUS$680.0011.259.6%n/aPharmaceuticals & Biotech
KEBNI B
SEK 1.08-0.7%-58.6%SEK 296.0mSEK 1.252.690.9%n/aTech
AXSM
US$238.377.5%137.4%US$12.4bUS$282.5117.357.0%n/aPharmaceuticals & Biotech
LPK
€14.75-0.7%77.1%€360.7m€22.753.6116.6%0%Tech
CDR
zł234.501.8%-6.1%zł23.4bzł235.1345.430.7%0.4%Media
WAYS
SEK 38.20-2.1%-4.5%SEK 335.0mSEK 58.00203.378.5%0%Tech
AGP
€6.90-2.5%-9.2%€125.8m€8.5725.339.1%n/aCapital Goods
SAUD3
R$14.971.4%25.2%R$43.8bR$16.6277.543.7%5.4%Healthcare
CORT
US$91.12-0.5%31.8%US$10.2bUS$92.00209.547.8%n/aPharmaceuticals & Biotech
NVDA
US$196.51-3.3%11.2%US$5.0tUS$302.8329.822.8%0.5%Semiconductors
RHM
€1,050.606.1%-37.4%€49.0b€1,697.8546.630.6%1.1%Capital Goods
LITE
US$711.96-7.0%564.3%US$59.4bUS$1,104.89126.256.5%n/aTech
CRDO
US$208.14-1.9%92.8%US$39.7bUS$279.2982.227.7%n/aSemiconductors
Page 1 of 42
Healthy high growth potential - Investing Ideas - Simply Wall St